What does Libtayo do to your organs?

A MySkinCancerTeam Visitor asked a question 💭
July 11
Immunotherapy for Skin Cancer: How It Works Read Article...
MySkinCancerTeam

Libtayo (cemiplimab) is an immunotherapy drug used to treat certain skin cancers, including advanced squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). It works by helping your immune system recognize and attack cancer cells.

Because it activates the immune system, Libtayo can sometimes cause it to mistakenly Show Full Answer

Libtayo (cemiplimab) is an immunotherapy drug used to treat certain skin cancers, including advanced squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). It works by helping your immune system recognize and attack cancer cells.

Because it activates the immune system, Libtayo can sometimes cause it to mistakenly attack healthy organs. These are called immune-related side effects, and they can affect several parts of the body, including:

- Lungs – inflammation (pneumonitis), causing cough or shortness of breath
- Liver – hepatitis, which may show up in blood tests
- Intestines – colitis, causing diarrhea or stomach pain
- Kidneys – nephritis, affecting how well they filter waste
- Skin – rashes or blistering
- Hormone-producing glands – such as the thyroid, pituitary, or adrenal glands

Most of these side effects are manageable if caught early, which is why regular monitoring during treatment is so important.

It's really worth having an open conversation with your oncologist or dermatologist about any new symptoms you notice while on Libtayo — even ones that seem minor. Early reporting can make a big difference in how quickly side effects are addressed.

July 11
All updates must be accompanied by text or a picture.

Related Questions

View All

What else can you do to prevent melanoma cancer cells from spreading

A MySkinCancerTeam Visitor asked a question 💭

Do you have any habits that help you stay on top of your sun protection?

A MySkinCancerTeam Subscriber asked a question 💭

Was there a moment when you realized, "Okay, this isn't going away"?

A MySkinCancerTeam Subscriber asked a question 💭